Search for: "Pfizer Inc." Results 861 - 880 of 1,379
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jun 2010, 6:01 pm by Duncan
(Patent Docs) Sutent (Sunitinib) – US: Patent infringement complaint filed following a Paragraph IV certification: Pfizer Inc. et al. v. [read post]
13 Oct 2006, 5:00 pm
Sampson IP Analytics, Caterpillar, Inc, Peoria, IllinoisElectronic Patent Office (US e-filing PCT-SAFE, EPO e-filing) by Carl Oppedahl - Oppedahl and Olson LLP, Dillon, ColoradoBest practices: Patent Management Boards for Invention Screening, annuity decisions - A CPS Roundtable Discussion led by Dean Olson (Moderator) - Senior Corporate Counsel, Pfizer, Inc., Groton, ConnecticutDesign Patents, Trade Dress, EU Community Design Utility models - Compare & Contrast by… [read post]
12 Oct 2010, 8:56 pm by Kelly
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
29 Jun 2015, 9:36 am
A futuristic Neil imagines a time when consumers’ psychological/neurological associations could be measured (also) for the sake of assess a trade marks’ reputation* Case management decisions in the Lyrica caseThe ongoing case between Warner-Lambert (a subsidiary of Pfizer) and Actavis concerning pregabalin (sold by Pfizer under the trade mark Lyrica, and by Actavis under the trade mark Lecaent) seems set to be the case of the year, Darren says. [read post]
10 Jun 2015, 6:00 am by JB
The NLDC wanted to redevelop an economically troubled neighborhood in conjunction with Pfizer, Inc., a major pharmaceutical firm that had set up a headquarters nearby and expected to benefit from the takings.The sad history of the project does indeed highlight some of the weaknesses of the Kelo decision. [read post]
10 Aug 2010, 8:44 pm by Marie Louise
  Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
18 Aug 2010, 1:34 pm by WIMS
    Companies that participated in the road testing exercise include: 3M, Abengoa, Acer Inc, Airbus S.A.S, AkzoNobel, Alcoa, Amcor, Ampacet, Anvil Knitwear, Inc., Autodesk, Inc., Baoshan Iron & Steel Co. [read post]
5 Jul 2007, 10:37 am
Squibb & Sons, Inc., 682 P.2d 832, 835 (Utah 1984).Virginia: Pfizer, Inc. v. [read post]
20 Sep 2024, 4:00 am by Alan Macek
As Justice Hughes said in Pfizer Canada Inc. v. [read post]
17 Apr 2012, 4:30 am
., Solutia, Inc., Pharmacia Corp., and Pfizer, Inc., in the Circuit Court of St. [read post]
30 Nov 2016, 11:32 am by David C. Scileppi
He has devoted his career to governance in his prior positions with companies such as Pfizer; CA, Inc.; and W.R. [read post]